MedTrace Logo

Antigen Presentation and Lymphocyte Response in Parkinson's Disease

NCT02939534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2021-02-21

No results posted yet for this study

Summary

The way the immune system responds to certain PD-related proteins in PD donors compared to the way it responds in persons without or fewer PD related proteins is not well studied and this study aims to analyze the autoimmune response in each group. The study involves a one time visit involving brief questionnaires and a blood draw of 30 mL (approximately 2 tablespoons) to be collected.

Conditions

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • Columbia University

    lead OTHER

Principal Investigators

  • Roy Alcalay, MD · Columbia University

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02939534 on ClinicalTrials.gov